SAN CARLOS, Calif., Mar 07, 2007 (BUSINESS WIRE) -- Nektar Therapeutics (Nasdaq:NKTR) will be presenting a company overview and update at two conferences in the next few weeks.
1. Cowen & Company 27th Annual Global Health Care Conference in Boston, on Tuesday, March 13, 2007 at 2:30pm (Eastern Time) with Howard W. Robin, president and CEO, as the speaker.
2. Lehman Brothers Tenth Annual Health Care Conference in South Beach, Florida, on Tuesday, March 20, 2007 at 1:30pm (Eastern Time), with Howard W. Robin, president and CEO, as the speaker.
The live presentations will be webcast and may be accessed on the Investor Relations' page at www.nektar.com and will be available for two weeks following each webcast.
Nektar Therapeutics is a biopharmaceutical company with a mission to develop and enable differentiated therapeutics with its industry-leading pulmonary and PEGylation technologies, expertise and manufacturing capabilities. Nektar technology and know-how have enabled nine approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar is also developing its own products by applying its technologies and expertise to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.
SOURCE: Nektar Therapeutics
Nektar Therapeutics Joyce Strand, 650-631-3138
Copyright Business Wire 2007
News Provided by COMTEX